Transcription of [P] Midazolam - Palliative Care
{{id}} {{{paragraph}}}
Medi cati on & Admi ni s trati on Medi ci nes & Infus i on Protocol s (Adul ts )/ 1d Pal l iati ve Care Midazolam Subcutaneous and Nasal- Palliative Care (Adults) 36 Issued by Pharmacy & Hospital Palliative Care Team Issued Date July 2016 Classification 014-001-01-073 Authorised by P&T Committee Review Period 36 months Page 1 of 6 This information is correct at date of issue. Always check on Waitemata DHB Controlled Documents site that this is the most recent version. Contents 1. Overview .. 1 2. Presentation .. 1 3. Indications .. 2 4. Dose .. 2 Subcutaneous Mi dazolam ..2 Mi dazol am Nasal Spray ..2 Dos e Convers i 5. Administration .. 3 Dil uent ..3 Addi ti onal Equi Compati bili ty.
hydrobromide, metoclopramide, ketamine, methadone, fentanyl, oxycodone, levomepromazine, hyoscine butylbromide, octreotide, glycopyrrolate ... The Syringe Driver – Continuous subcutaneous infusions in palliative care. 3 rd ed. New York: Oxford university press; 2011. 6 New Zealand Formulary online, release 47-1 May 2016 – Midazolam ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}